Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma

Results of a study investigating tucidinostat combined with chemoimmunotherapy for treatment of double hit DLBCL.